Healthcare > Diagnostics & Lab Services
•30 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (30)
| Company | Market Cap | Price |
|---|---|---|
|
LH
Labcorp Holdings Inc.
Labcorp operates a network of clinical laboratories delivering diagnostic testing services.
|
$23.28B |
$280.87
-0.75%
|
|
DGX
Quest Diagnostics Incorporated
Quest Diagnostics operates a nationwide network of clinical labs, i.e., clinical lab chains delivering diagnostic testing services.
|
$23.19B |
$208.43
+0.03%
|
|
EXAS
Exact Sciences Corporation
The company operates clinical laboratory testing capabilities as part of delivering its diagnostic products and services.
|
$19.61B |
$103.50
+0.13%
|
|
GH
Guardant Health, Inc.
Clinical Lab Chains: Guardant operates CLIA-certified lab operations to process tests.
|
$11.72B |
$93.16
-0.16%
|
|
DVA
DaVita Inc.
DaVita operates clinical laboratory testing facilities and diagnostic services as part of its dialysis and kidney care offerings.
|
$10.84B |
$154.72
+1.61%
|
|
TEM
Tempus AI, Inc.
Clinical Lab Chains – Tempus operates clinical laboratories delivering sequencing-based diagnostics, expanded by the Ambry Genetics acquisition.
|
$9.12B |
$51.26
-0.27%
|
|
SHC
Sotera Health Company
Nelson Labs operates clinical lab testing facilities, i.e., lab chains, as part of its testing services.
|
$4.48B |
$15.73
+0.22%
|
|
HIMS
Hims & Hers Health, Inc.
Clinical laboratory chains / lab testing services through Trybe Labs.
|
$3.74B |
$16.45
+3.95%
|
|
CON
Concentra Group Holdings Parent, Inc.
The business provides diagnostic testing via its clinics, aligning with laboratory testing and diagnostic service capabilities.
|
$3.02B |
$23.55
+0.32%
|
|
ADPT
Adaptive Biotechnologies Corporation
Partnership activity with NeoGenomics reflects ADPT's role in clinical lab testing services / lab chains.
|
$2.51B |
$16.44
+2.24%
|
|
NEOG
Neogen Corporation
Genomics services and diagnostic testing capabilities may be organized or delivered through clinical lab networks, aligning with Clinical Lab Chains.
|
$2.35B |
$10.80
-0.92%
|
|
WGS
GeneDx Holdings Corp.
Clinical lab chains providing genetic testing services.
|
$2.30B |
$79.50
+3.29%
|
|
GRAL
GRAIL, Inc.
Company operates clinical laboratory testing capabilities to run Galleri and related studies.
|
$1.95B |
$52.83
+0.13%
|
|
QDEL
QuidelOrtho Corporation
Clinical lab chains/diagnostic service networks align with QuidelOrtho’s lab-based business model and scale.
|
$1.44B |
$21.18
-1.40%
|
|
NEO
NeoGenomics, Inc.
NeoGenomics operates a network of cancer-focused testing laboratories, i.e., clinical lab chains.
|
$1.18B |
$9.10
-4.61%
|
|
AZTA
Azenta, Inc.
Genewiz operates as a clinical lab network, aligning with Clinical Lab Chains.
|
$1.15B |
$25.12
+2.38%
|
|
CDNA
CareDx, Inc
Operates as Clinical Lab Chains or core laboratory testing facilities providing diagnostic services.
|
$980.31M |
$19.06
+1.38%
|
|
MYGN
Myriad Genetics, Inc.
Clinical lab chains—multiplicity of testing locations and labs enabling national testing services.
|
$492.17M |
$5.29
-0.09%
|
|
FLGT
Fulgent Genetics, Inc.
Company operates clinical lab chains providing diagnostic testing.
|
$432.46M |
$14.02
+1.67%
|
|
SOPH
SOPHiA GENETICS S.A.
Clinical Lab Chains: target customers include clinical laboratories and networks leveraging the platform.
|
$286.65M |
$4.22
+2.93%
|
|
BNR
Burning Rock Biotech Limited
Operates clinical laboratory testing facilities (central lab/in-hospital model).
|
$236.69M |
$22.29
-5.31%
|
|
XGN
Exagen Inc.
Exagen’s core diagnostic testing capability places it within clinical lab chains as a diagnostic testing provider.
|
$78.99M |
$3.59
+4.66%
|
|
AKYA
Akoya Biosciences, Inc.
Clinical lab chains alignment with the company’s lab services and clinical testing offerings.
|
$64.26M |
$1.29
|
|
CDIX
Cardiff Lexington Corporation
Nova Ortho & Spine provides diagnostic and related assessment services, aligning with Diagnostics & Lab Services in Healthcare.
|
$58.28M |
$3.95
|
|
PRPO
Precipio, Inc.
Pathology/clinical lab services and diagnostic testing operations.
|
$43.45M |
$26.61
+5.78%
|
|
TRIB
Trinity Biotech plc
Operates Immco NYSDOH-certified clinical laboratory for diagnostic testing.
|
$12.57M |
$0.70
+1.47%
|
|
BNGO
Bionano Genomics, Inc.
BNGO has historically operated Clinical Lab Chains as part of its diagnostic services portfolio.
|
$7.35M |
$1.55
-1.27%
|
|
APM
Aptorum Group Limited
Diagnostics platform potentially operating as a network of clinical labs; reflects lab-based service delivery.
|
$4.63M |
$0.80
+0.78%
|
|
POAI
Predictive Oncology Inc.
CLIA-certified wet-lab operations and clinical-lab-style testing/validation services.
|
$4.32M |
$5.94
-0.17%
|
|
BIAF
bioAffinity Technologies, Inc.
The company operates clinical laboratory testing facilities as part of CyPath Lung, aligning with 'Clinical Lab Chains'.
|
$977412 |
$1.04
+9.39%
|
Loading company comparison...
Loading industry trends...
Loading research report...
